+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stilnox"

Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
Stilnox - API Insight, 2022 - Product Thumbnail Image

Stilnox - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Stilnox- Drug Insight, 2019 - Product Thumbnail Image

Stilnox- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Stilnox is a brand of zolpidem, a sedative-hypnotic drug used to treat insomnia. It is classified as a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to produce its effects. Stilnox works by binding to the same receptors in the brain as benzodiazepines, but with a much weaker effect. It is used to treat short-term insomnia, and is generally considered to be safe and effective when taken as prescribed. Stilnox is available in tablet form and is typically taken orally. It is available in a variety of strengths, ranging from 5mg to 10mg. It is important to note that Stilnox should not be taken with alcohol or other CNS depressants, as this can increase the risk of side effects. Some of the companies in the Stilnox market include Sanofi-Aventis, Mylan, and Teva Pharmaceuticals. Show Less Read more